Takeda Pharmaceutical (TAK) Divestments (2018 - 2026)

Takeda Pharmaceutical has reported Divestments for 9 years, with the latest figure at $65.6 million in Q2 2026.

• On a quarterly basis, Divestments fell 67.58% year-over-year to $65.6 million in Q2 2026; TTM through Jun 2026 was $312.1 million, a 2.08% decrease from a year earlier, with the FY2026 full-year figure at $212.5 million, up 57.47% from the prior year.
• Divestments was $65.6 million for Q2 2026 at Takeda Pharmaceutical, up from $3.3 million in the prior quarter.
• The five-year high for Divestments was $224.2 million in Q1 2022, with the low at $2.7 million in Q2 2023.
• Average Divestments over 5 years is $68.7 million, with a median of $20.6 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Divestments slumped 98.65% in 2023, then jumped 4272.26% in 2024.
• Over 5 years, Divestments stood at $15.2 million in 2022, then slumped by 81.78% to $2.8 million in 2023, then soared by 199.23% to $8.3 million in 2024, then soared by 148.14% to $20.6 million in 2025, then surged by 219.16% to $65.6 million in 2026.
• The last three Divestments figures came in at $65.6 million (Q2 2026), $3.3 million (Q1 2026), and $20.6 million (Q4 2025), per Business Quant data.